Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors
Myeloid Therapeutics
Myeloid Therapeutics
Incyte Corporation
Novartis
Avenzo Therapeutics, Inc.
Pfizer
Nurix Therapeutics, Inc.
Xencor, Inc.
858 Therapeutics, Inc.
Medicenna Therapeutics, Inc.
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
Klus Pharma Inc.
Theratechnologies
Exelixis
Pfizer
Cybrexa Therapeutics
Carisma Therapeutics Inc
Light Chain Bioscience - Novimmune SA
Salubris Biotherapeutics Inc
Valerio Therapeutics
Eli Lilly and Company
BioEclipse Therapeutics
Multitude Therapeutics Inc.
Pfizer
Xencor, Inc.
Corcept Therapeutics
MacroGenics
Gilead Sciences
Mitra RxDx, Inc.
Pfizer
INSYS Therapeutics Inc